African American participation in cancer clinical trials

BACKGROUND: According to the Food and Drug Administration, African Americans (AAs) have been habitually underrepresented in cancer clinical trials (CCTs). This under-enrolment has contributed to cancer disparities despite the implementation of policies to improve AA accrual. This systematic review a...

Descripción completa

Detalles Bibliográficos
Autores principales: Swaby, Jordan, Kaninjing, Ernie, Ogunsanya, Motolani
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580719/
https://www.ncbi.nlm.nih.gov/pubmed/34824630
http://dx.doi.org/10.3332/ecancer.2021.1307

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580719/
https://www.ncbi.nlm.nih.gov/pubmed/34824630
http://dx.doi.org/10.3332/ecancer.2021.1307

Ejemplares similares